Publicacións en colaboración con investigadores/as de Leeds and York Partnership NHS Foundation Trust (15)

2020

  1. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

2019

  1. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia

    Schizophrenia Bulletin, Vol. 45, Núm. 2, pp. 305-314

  2. Psychological interventions for people with psychotic experiences: Protocol for a systematic review and meta-Analysis

    Systematic Reviews, Vol. 8, Núm. 1

  3. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436

  4. Transdiagnostic dimensions of psychopathology at first episode psychosis: Findings from the multinational EU-GEI study

    Psychological Medicine, Vol. 49, Núm. 8, pp. 1378-1391

2018

  1. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807

  2. Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy

    Muscle and Nerve, Vol. 57, Núm. 3, pp. 380-387

  3. Inverse association between negative symptoms and body mass index in chronic schizophrenia

    Schizophrenia Research, Vol. 192, pp. 69-74

  4. Obstetric Phenotypes in the Heterogeneity of Schizophrenia

    Journal of Nervous and Mental Disease, Vol. 206, Núm. 11, pp. 882-886

2017

  1. Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis

    Schizophrenia Research, Vol. 179, pp. 57-63

  2. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

    Expert Opinion on Pharmacotherapy, Vol. 18, Núm. 18, pp. 1987-1999

2016

  1. Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis

    Schizophrenia Research, Vol. 174, Núm. 1-3, pp. 156-160

  2. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer

    Journal of Thoracic Oncology, Vol. 11, Núm. 1, pp. 39-51

2015

  1. The negative syndrome of schizophrenia: Three -underlying components are better than two

    Schizophrenia Research, Vol. 166, Núm. 1-3, pp. 115-118

2014

  1. Spanish adaptation and validation of the Brief Negative Symptoms Scale

    Comprehensive Psychiatry, Vol. 55, Núm. 7, pp. 1726-1729